Skip to main content

Advertisement

Log in

Lower urinary tract symptoms in relation to region of birth in 95,393 men living in Australia: the 45 and Up Study

  • Original Article
  • Published:
World Journal of Urology Aims and scope Submit manuscript

Abstract

Purpose

Lower urinary tract symptoms (LUTS) are very common among older men globally, but evidence regarding the relationship between LUTS and country of origin is limited. This study aimed to investigate the relationship between the prevalence of LUTS and region of birth in a large, ethnically diverse population of older men resident in New South Wales, Australia.

Methods

Data on LUTS, demographic and behavioural factors were collected by postal questionnaire from 2006 to 2009 and analysed for 95,393 men aged 45 and over from the 45 and Up Study, who had not had previous prostate surgery. Logistic regression was used to investigate the association between region of birth and moderate/severe LUTS, ascertained using a modified International Prostate Symptom Score, adjusting for age, income, education, alcohol consumption and smoking.

Results

Overall, 18,530 (19.4 %) men had moderate or severe LUTS. Compared to Australian-born men, prevalence of moderate/severe LUTS was significantly higher in men born in the Middle East & North Africa, Southeast Asia and North America regions (adjusted odds ratios (OR) = 1.43; 95 % CI = 1.23–1.66, OR = 1.25; 1.10–1.42, OR = 1.26; 1.05–1.52, respectively), whereas men from the UK & Ireland had significantly lower prevalence (OR = 0.85; 0.80–0.90). Patterns of association were generally similar for storage- and voiding-related types of LUTS. However, participants born in Sub-Saharan Africa showed a significantly elevated prevalence of moderate/severe voiding symptoms (1.22; 1.03–1.45) but not storage symptoms, compared to Australian-born respondents.

Conclusion

The prevalence of LUTS and of specific subtypes of LUTS varies according to region of birth.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Meigs JB, Mohr B, Barry MJ, Collins MM, McKinlay JB (2001) Risk factors for clinical benign prostatic hyperplasia in a community-based population of healthy aging men. J Clin Epidemiol 54(9):935–944

    Article  PubMed  CAS  Google Scholar 

  2. Holden C, McLachlan R, Pitts M, Cumming RG, Wittert G, Agius P, Handelsman D, de Kretser D (2005) Men in Australia Telephone Survey (MATeS): a national survey of the reproductive health and concerns of middle-aged and older Australian men. Lancet 366:218–224

    Article  PubMed  Google Scholar 

  3. Ward J, Sladden M (1994) Urinary symptoms in older men, their investigation and management: is there an epidemic of undetected morbidity in the waiting room? Fam Pract 11(3):251–259. doi:10.1093/fampra/11.3.251

    Article  PubMed  CAS  Google Scholar 

  4. Thorpe A, Neal D (2003) Benign prostatic hyperplasia. The Lancet 361(9366):1359–1367

    Article  CAS  Google Scholar 

  5. Kang D, Andriole GL, Van De Vooren RC, Crawford D, Chia D, Urban DA, Reding D, Huang WY, Hayes RB (2004) Risk behaviours and benign prostatic hyperplasia. BJU Int 93(9):1241–1245

    Article  PubMed  CAS  Google Scholar 

  6. Roberts RO, Tsukamoto T, Kumamoto Y, Rhodes T, Masumori N, Miyake H, Girman CJ, Jacobsen SJ, Lieber MM (1997) Association between cigarette smoking and prostatism in a Japanese community. Prostate 30(3):154–159. doi:10.1002/(sici)1097-0045(19970215)30:3<154::aid-pros2>3.0.co;2-m

    Article  PubMed  CAS  Google Scholar 

  7. Giovannucci E, Rimm EB, Chute CG, Kawachi I, Colditz GA, Stampfer MJ, Willett WC (1994) Obesity and benign prostatic hyperplasia. Am J Epidemiol 140(11):989–1002

    PubMed  CAS  Google Scholar 

  8. Parsons JK, Kashefi C (2008) Physical activity, benign prostatic hyperplasia, and lower urinary tract symptoms. Eur Urol 53(6):1228–1235

    Article  PubMed  Google Scholar 

  9. Platz EA, Kawachi I, Rimm EB, Colditz GA, Stampfer MJ, Willett WC, Giovannucci E (1998) Physical activity and benign prostatic hyperplasia. Arch Intern Med 158(21):2349–2356. doi:10.1001/archinte.158.21.2349

    Article  PubMed  CAS  Google Scholar 

  10. Suzuki S, Platz EA, Kawachi I, Willett WC, Giovannucci E (2002) Intakes of energy and macronutrients and the risk of benign prostatic hyperplasia. Am J Clin Nutr 75(4):689–697

    PubMed  CAS  Google Scholar 

  11. Rohrmann S, Giovannucci E, Willett WC, Platz EA (2007) Fruit and vegetable consumption, intake of micronutrients, and benign prostatic hyperplasia in US men. Am J Clin Nutr 85(2):523–529

    PubMed  CAS  Google Scholar 

  12. Ambrosini GL, De Klerk NH, Mackerras D, Leavy J, Fritschi L (2008) Dietary patterns and surgically treated benign prostatic hyperplasia: a case control study in Western Australia. BJU Int 101(7):853–860. doi:10.1111/j.1464-410X.2007.07345.x

    Article  PubMed  Google Scholar 

  13. Fitzgerald MP, Link CL, Litman HJ, Travison TG, McKinlay JB (2007) Beyond the lower urinary tract: the association of urologic and sexual symptoms with common illnesses. Eur Urol 52(2):407–415

    Article  PubMed  Google Scholar 

  14. Kristal AR, Schenk JM, Song Y, Arnold KB, Neuhouser ML, Goodman PJ, Lin DW, Stanczyk FZ, Thompson IM (2008) Serum steroid and sex hormone-binding globulin concentrations and the risk of incident benign prostatic hyperplasia: results from the prostate cancer prevention trial. Am J Epidemiol 168(12):1416–1424. doi:10.1093/aje/kwn272

    Article  PubMed  Google Scholar 

  15. Neuhouser ML, Schenk J, Song YJ, Tangen CM, Goodman PJ, Pollak M, Penson DF, Thompson IM, Kristal AR (2008) Insulin-like growth factor-I, insulin-like growth factor binding protein-3 and risk of benign prostate hyperplasia in the prostate cancer prevention trial. Prostate 68(13):1477–1486. doi:10.1002/pros.20819

    Article  PubMed  Google Scholar 

  16. Safarinejad MR (2008) Prevalence of benign prostatic hyperplasia in a population-based study in Iranian men 40 years old or older. Int Urol Nephrol 40(4):921–931

    Article  PubMed  Google Scholar 

  17. Fritschi L, Tabrizi J, Leavy J, Ambrosini G, Timperio A (2007) Risk factors for surgically treated benign prostatic hyperplasia in Western Australia. Public Health 121(10):781–789

    Article  PubMed  Google Scholar 

  18. Kristal AR, Arnold KB, Schenk JM, Neuhouser ML, Weiss N, Goodman P, Antvelink CM, Penson DF, Thompson IM (2007) Race/ethnicity, obesity, health related behaviors and the risk of symptomatic benign prostatic hyperplasia: results from the prostate cancer prevention trial. J Urol 177(4):1395–1400 quiz 1591

    Article  PubMed  Google Scholar 

  19. Jin B, Turner L, Zhou Z, Zhou EL, Handelsman DJ (1999) Ethnicity and migration as determinants of human prostate size. J Clin Endocrinol Metab 84(10):3613–3619. doi:10.1210/jc.84.10.3613

    Article  PubMed  CAS  Google Scholar 

  20. Morrison AS (1992) Risk factors for surgery for prostatic hypertrophy. Am J Epidemiol 135(9):974–980

    PubMed  CAS  Google Scholar 

  21. Platz EA, Kawachi I, Rimm EB, Willett WC, Giovannucci E (2000) Race, ethnicity and benign prostatic hyperplasia in the health professionals follow-up study. J Urol 163(2):490–495

    Article  PubMed  CAS  Google Scholar 

  22. Sladden MJ, Hughes AM, Hirst GH, Ward JE (2000) A community study of lower urinary tract symptoms in older men in Sydney, Australia. Aust N Z J Surg 70(5):322–328

    Article  PubMed  CAS  Google Scholar 

  23. Gupta A, Gupta S, Pavuk M, Roehrborn CG (2006) Anthropometric and metabolic factors and risk of benign prostatic hyperplasia: a prospective cohort study of Air Force veterans. Urology 68(6):1198–1205

    Article  PubMed  Google Scholar 

  24. Sidney S, Quesenberry CP Jr, Sadler MC, Guess HA, Lydick EG, Cattolica EV (1991) Incidence of surgically treated benign prostatic hypertrophy and of prostate cancer among blacks and whites in a prepaid health care plan. Am J Epidemiol 134(8):825–829

    PubMed  CAS  Google Scholar 

  25. Welch G, Kawachi I, Barry MJ, Giovannucci E, Colditz GA, Willett WC (1998) Distinction between symptoms of voiding and filling in benign prostatic hyperplasia: findings from the health professionals follow-up study. Urology 51(3):422–427

    Article  PubMed  CAS  Google Scholar 

  26. Banks E, Redman S, Jorm L, Armstrong B, Bauman A, Beard J, Beral V, Byles J, Corbett S, Cumming R (2008) Cohort profile: the 45 and Up Study. Int J Epidemiol 37(5):941–947. doi:10.1093/ije/dym184

    Article  PubMed  Google Scholar 

  27. Barry MJ, Fowler FJ Jr, O’Leary MP, Bruskewitz RC, Holtgrewe HL, Mebust WK, Cockett AT (1992) The American Urological Association symptom index for benign prostatic hyperplasia, the measurement committee of the American Urological Association. J Urol 148(5):1549–1557

    PubMed  CAS  Google Scholar 

  28. Harvard University, Institute for health metrics and evaluation at the University of Washington, Johns Hopkins University, University of Queensland, World Health Organization (2007) The global burden of diseases, injuries, and risk factors operations manual (draft)

  29. World Health Organization (1998) Obesity: preventing and managing the global epidemic. World Health Organization, Geneva

    Google Scholar 

  30. Dirks J, Remuzzi G, Horton S, Schieppati A, Hasan Rizvi SA (2006) Diseases of the kidney and the urinary system. In: Jamison DT, Breman JG, Measham AR et al (eds) Disease control priorities in developing countries, 2nd edn. Oxford University Press, New York

    Google Scholar 

  31. Hochreiter WW, Bushman W (1999) Urinary tract infection: a moving target. World J Urol 17(6):364–371. doi:10.1007/s003450050162

    Article  PubMed  CAS  Google Scholar 

  32. Ziegler RG, Hoover RN, Pike MC, Hildesheim A, Nomura AMY, West DW, Wu-Williams AH, Kolonel LN, Horn-Ross PL, Rosenthal JF, Hyer MB (1993) Migration patterns and breast cancer risk in Asian–American women. J Natl Cancer Inst 85(22):1819–1827. doi:10.1093/jnci/85.22.1819

    Article  PubMed  CAS  Google Scholar 

  33. Australian Bureau of Statistics (2006) Census of population and housing. Commonwealth of Australia

  34. Mealing NM, Banks E, Jorm LR, Steel DG, Clements MS, Rogers KD (2010) Investigation of relative risk estimates from studies of the same population with contrasting response rates and designs. BMC Med Res Methodol 10:26. doi:10.1186/1471-2288-10-26

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

The authors would like to thank the men participating in the 45 and Up Study. The 45 and Up Study is managed by The Sax Institute in collaboration with major partner Cancer Council New South Wales; and partners the National Heart Foundation of Australia (NSW Division); NSW Ministry of Health; beyondblue: the national depression initiative; Ageing, Disability and Home Care, Department of Human Services NSW; and the Red Cross Blood Service. Emily Banks is supported by the National Health and Medical Research Council.

Conflict of interest

None.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Emily Banks.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary material 1 (PDF 89 kb)

Rights and permissions

Reprints and permissions

About this article

Cite this article

Latz, I., Weber, M., Korda, R. et al. Lower urinary tract symptoms in relation to region of birth in 95,393 men living in Australia: the 45 and Up Study. World J Urol 31, 673–682 (2013). https://doi.org/10.1007/s00345-012-0937-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00345-012-0937-7

Keywords

Navigation